Cohen Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$577K Buy
9,512
+63
+0.7% +$3.67K 0.27% 57
2025
Q4
$510K Sell
9,449
-20
-0.2% -$962 0.23% 59
2025
Q3
$427K Buy
9,469
+1,180
+14% +$55.1K 0.21% 69
2025
Q2
$384K Sell
8,289
-490
-6% -$24.1K 0.2% 70
2025
Q1
$535K Sell
8,779
-23
-0.3% -$1.34K 0.31% 52
2024
Q4
$498K Buy
8,802
+221
+3% +$12.3K 0.3% 54
2024
Q3
$444K Buy
8,581
+962
+13% +$45.1K 0.27% 62
2024
Q2
$442K Buy
7,619
+487
+7% +$21.8K 0.36% 57
2024
Q1
$387K Sell
7,132
-207
-3% -$10.5K 0.25% 60
2023
Q4
$377K Sell
7,339
-280
-4% -$14.7K 0.28% 65
2023
Q3
$442K Sell
7,619
-291
-4% -$17.8K 0.36% 57
2023
Q2
$506K Sell
7,910
-143
-2% -$9.59K 0.41% 57
2023
Q1
$558K Buy
8,053
+476
+6% +$33.6K 0.44% 51
2022
Q4
$545K Buy
7,577
+395
+5% +$29.8K 0.45% 50
2022
Q3
$511K Sell
7,182
-10
-0.1% -$725 0.47% 48
2022
Q2
$554K Sell
7,192
-59
-0.8% -$4.49K 0.47% 46
2022
Q1
$530K Buy
7,251
+90
+1% +$6.04K 0.39% 53
2021
Q4
$446K Buy
7,161
+61
+0.9% +$3.58K 0.32% 61
2021
Q3
$420K Buy
7,100
+41
+0.6% +$2.7K 0.32% 60
2021
Q2
$472K Buy
7,059
+57
+0.8% +$3.72K 0.37% 52
2021
Q1
$442K Sell
7,002
-35
-0.5% -$2.18K 0.36% 56
2020
Q4
$437K Buy
+7,037
New +$433K 0.39% 52

Other funds holding BMY

Cohen Investment Advisors's BMY Position: Q1 2026 in Review

Cohen Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.67% in Q1 2026, buying an estimated $3.67K and bringing the position to 9,512 shares worth $577K. The position accounts for 0.27% of the portfolio, ranked #57.

Cohen Investment Advisors first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Cohen Investment Advisors held 9,512 shares of Bristol-Myers Squibb worth $577K as of Q1 2026.
  • Cohen Investment Advisors bought 63 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.67K.
  • Bristol-Myers Squibb made up 0.27% of Cohen Investment Advisors's portfolio in Q1 2026, its #57 holding.
  • Cohen Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Cohen Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.